Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1145
-0.0015 (-1.29%)
Jul 24, 2026, 3:03 PM CET

Spago Nanomedical AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.384.826.915.936.466.53
Revenue Growth
-37.31%-30.25%16.56%-8.19%-1.10%-9.85%
Gross Profit
4.384.826.915.936.466.53
Operating Income
-26.39-26.94-33.71-43.07-39.47-39.19
Net Income
-25.92-26.55-32.51-42.22-39.2-39.07
Earnings Per Share
-0.06-0.07-0.11-0.43-0.67-1.10
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
25.9229.6732.4745.2262.152.46
Total Debt
000000
Net Cash (Debt)
25.9229.6732.4745.2262.152.46
Net Cash Growth
-2.46%-8.62%-28.19%-27.19%18.38%84.41%
Net Cash Per Share
0.060.080.090.430.971.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.13-28.3-34.67-44.91-38.19-35.57
Capital Expenditures
----0.15-0.13-0.37
Free Cash Flow
-25.13-28.3-34.67-45.06-38.32-35.94
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-601.85%-558.77%-487.68%-726.24%-610.91%-600.00%
Pretax Margin
-591.17%-550.68%-470.26%-711.90%-606.76%-598.15%
Profit Margin
-591.17%-550.68%-470.26%-711.90%-606.77%-598.15%
FCF Margin
-573.15%-586.83%-501.49%-759.77%-593.20%-550.25%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-1.901.901.903.6045.71
PS Ratio
17.2815.989.8710.408.8730.26